People · Operator
Named in public records as an officer, director or promoter · active 2010–2018 · Biotechnology, Pharmaceuticals, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cidara Therapeutics, Inc. | — | Biotechnology | Series D+ | $349.1M | $2.8B | 2017 |
| Relypsa Inc | — | Biotechnology | Series C | $292.3M | $2.7B | 2010 |
| Novira Therapeutics, Inc. | — | Pharmaceuticals | Series B | $48.0M | $306.0M | 2014 |
| Waverx Inc | — | Other Health Care | Pre-Seed | $503K | $15.5M | 2010 |
Scott M. Rocklage at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Scott M. Rocklage on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| SCOTT ROCKLAGE | 2 | 9 |
| Nina Kjellson | 1 | 11 |
| Patrick Heron | 1 | 11 |
| Tim Shannon | 1 | 9 |
| Steve Elms | 1 | 4 |
| Theodore R. Schroeder | 1 | 4 |
| Jeffrey Stein | 1 | 4 |
| Kevin Forrest | 1 | 3 |
| Dirk Thye | 1 | 3 |
| Daniel E. Geffken | 1 | 3 |
| Daniel D. Burgess | 1 | 3 |
| Kevin Judice | 1 | 3 |
| Gerrit Klaerner | 1 | 3 |
| Gianni Gromo | 1 | 2 |
| Timothy R. Franson | 1 | 2 |
| Deepa M. Pakianathan | 1 | 2 |
| Vijay M. Lathi | 1 | 2 |
| Jay P. Shepard | 1 | 2 |
| Ron M. Hunt | 1 | 1 |
| Jerry M. Buysse | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.